Muzevich KM, Chohan H, Grinnan DC: Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness. Crit Care. 2014, 18: 523-10.1186/s13054-014-0523-z.
Article
Google Scholar
Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA: Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013, 188: 365-369. 10.1164/rccm.201209-1640OC.
Article
Google Scholar
Tonelli AR, Zein J, Ioannidis JP: Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther. 2013, 31: e138-e146. 10.1111/1755-5922.12050.
Article
CAS
Google Scholar
Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A: Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013, 62: D60-D72. 10.1016/j.jacc.2013.10.031.
Article
Google Scholar
Rubin LJ: Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci. 2012, 91: 517-521. 10.1016/j.lfs.2012.07.033.
Article
CAS
Google Scholar
Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF: Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998, 113: 237-240. 10.1378/chest.113.1.237.
Article
CAS
Google Scholar
Tonelli AR, Minai OA: Perioperative management in patients with pulmonary hypertension. Annals Thoracic Med. 2014, 9: S98-S107. 10.4103/1817-1737.134048.
Article
Google Scholar
Alkukhun L, Bair ND, Dweik RA, Tonelli AR: Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 4-8. 10.1097/FJC.0000000000000018.
Article
CAS
Google Scholar
Cheng JW, Tonelli AR, Pettersson G, Krasuski RA: Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 375-384. 10.1097/FJC.0000000000000050.
Article
CAS
Google Scholar
Dzierba AL, Abel EE, Buckley MS, Lat I: A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. Pharmacotherapy. 2014, 34: 279-290. 10.1002/phar.1365.
Article
CAS
Google Scholar
Siobal M: Aerosolized prostacyclins. Respir Care. 2004, 49: 640-652.
Google Scholar
Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M: The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012, 141: 36-42. 10.1378/chest.11-0245.
Article
CAS
Google Scholar
Kallen AJ, Lederman E, Balaji A, Trevino I, Petersen EE, Shoulson R, Saiman L, Horn EM, Gomberg-Maitland M, Barst RJ, Srinivasan A: Bloodstream infections in patients given treatment with intravenous prostanoids. Infect Control Hosp Epidemiol. 2008, 29: 342-349. 10.1086/529552.
Article
Google Scholar
Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL: Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl. 2008, 160: 5-9. 10.1111/j.1742-1241.2008.01811.x.
Article
Google Scholar